Measuring Human Lipid Metabolism Using Deuterium Labeling: In Vivo and In Vitro Protocols.
暂无分享,去创建一个
[1] L. Hodson,et al. In vitro cellular models of human hepatic fatty acid metabolism: differences between Huh7 and HepG2 cell lines in human and fetal bovine culturing serum , 2017, Physiological reports.
[2] S. Neubauer,et al. Fasting Plasma Insulin Concentrations Are Associated With Changes in Hepatic Fatty Acid Synthesis and Partitioning Prior to Changes in Liver Fat Content in Healthy Adults , 2016, Diabetes.
[3] S. Neubauer,et al. Sex-Specific Differences in Hepatic Fat Oxidation and Synthesis May Explain the Higher Propensity for NAFLD in Men. , 2015, The Journal of clinical endocrinology and metabolism.
[4] J. Borén,et al. De novo lipogenesis in metabolic homeostasis: More friend than foe? , 2015, Molecular metabolism.
[5] J. Browning,et al. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. , 2014, Gastroenterology.
[6] E. Ryan,et al. Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes , 2009, Diabetologia.
[7] S. O’Rahilly,et al. Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. , 2009, The Journal of clinical investigation.
[8] E. Parks,et al. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. , 2006, The Journal of clinical endocrinology and metabolism.
[9] J. Jessurun,et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.
[10] M. Beylot,et al. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. , 2003, Diabetes & metabolism.
[11] S. Wootton,et al. A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction* , 2000, British Journal of Nutrition.
[12] M. Casu,et al. N.m.r. lipid profiles of cells, tissues and body fluids. Neutral, non-acidic and acidic phospholipid analysis of Bond Elut chromatographic fractions. , 1993, The Biochemical journal.
[13] R Schoenheimer,et al. The Investigation of Intermediary Metabolism with the Aid of Heavy Hydrogen: Harvey Lecture, January 21, 1937. , 1937, Bulletin of the New York Academy of Medicine.
[14] D. Rittenberg,et al. DEUTERIUM AS AN INDICATOR IN THE STUDY OF INTERMEDIARY METABOLISM. , 1935, Science.
[15] E. Parks,et al. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis. , 2015, The American journal of clinical nutrition.
[16] E. Parks,et al. Temporal pattern of de novo lipogenesis in the postprandial state in healthy men. , 2005, The American journal of clinical nutrition.
[17] M. Beylot,et al. Measuring lipogenesis and cholesterol synthesis in humans with deuterated water: use of simple gas chromatographic/mass spectrometric techniques. , 1997, Journal of mass spectrometry : JMS.
[18] M. Hellerstein,et al. Regulation of hepatic de novo lipogenesis in humans. , 1996, Annual review of nutrition.